Lipocine Inc (LPCN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 115 | 623 | 94 | 3,491 | 0 |
| Gross Profit | 115 | 623 | 94 | 3,491 | N/A |
| Operating Expenses | 3,476 | 3,027 | 2,184 | 1,946 | 2,631 |
| Operating Income | -3,361 | -2,404 | -2,090 | 1,546 | -2,631 |
| Other Income | 174 | 199 | 226 | 237 | 412 |
| Pre-tax Income | -3,187 | -2,206 | -1,865 | 1,782 | -2,219 |
| Income Tax | N/A | N/A | 0 | 1 | N/A |
| Net Income Continuous | -3,187 | -2,206 | -1,865 | 1,781 | -2,219 |
| Net Income | $-3,187 | $-2,206 | $-1,865 | $1,782 | $-2,219 |
| EPS Basic Total Ops | -0.59 | -0.41 | -0.35 | 0.32 | -0.41 |
| EPS Basic Continuous Ops | -0.59 | -0.41 | -0.35 | 0.33 | -0.41 |
| EPS Diluted Total Ops | -0.59 | -0.41 | -0.35 | 0.35 | -0.44 |
| EPS Diluted Continuous Ops | -0.59 | -0.41 | -0.35 | 0.33 | -0.41 |
| EPS Diluted Before Non-Recurring Items | -0.59 | -0.41 | -0.35 | 0.33 | -0.44 |
| EBITDA(a) | $-3,381 | $-2,423 | $-2,133 | $1,443 | $-2,790 |